16,650
Views
165
CrossRef citations to date
0
Altmetric
Reviews

Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications

, , , , , & show all
Pages 788-799 | Received 16 Oct 2016, Accepted 22 Dec 2016, Published online: 08 Feb 2017

References

  • Ahmad I, Arsalan A, Ali SA, Bano R, Munir I, Sabah A. 2016. Formulation and stabilization of norfloxacin in liposomal preparations. Eur J Pharm Sci. 91:208–215.
  • Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. 2013. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8:1.
  • Akbarzadeh A, Samiei M, Davaran S. 2012. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett. 7:1.
  • Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, et al. 2012. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. J Nanobiotechnol. 10:1.
  • Allison SD. 2007. Liposomal drug delivery. J Infus Nurs. 30:89–95.
  • Al-Remawi M ,Elsayed A, Maghrabi I, Hamaidi M, Jaber N. 2016. Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system. Pharm Dev Technol. 1–9.
  • Alizadeh E, Akbarzadeh A, Eslaminejad Abolfazl Barzegar MB, Hashemzadeh S, Nejati-Koshki K, Zarghami N. 2015. Up regulation of liver-enriched transcription factors HNF4a and HNF6 and liver-specific microRNA (miR-122) by inhibition of let-7b in mesenchymal stem cells. Chem Biol Drug Des. 85:268–279.
  • Barenholz YC. 2012. Doxil®—the first FDA-approved nano-drug: lessons learned. J Control Release. 160:117–134.
  • Basha G, Novobrantseva T, Rosin IN, Tam YYC, Hafez IM, Wong MK, et al. 2011. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells. Mol Ther.
  • Bochot A, Fattal E. 2012. Liposomes for intravitreal drug delivery: a state of the art. J Control Release. 161:628–634.
  • Bottaro E, Nastruzzi C. 2016. “Off-the-shelf" microfluidic devices for the production of liposomes for drug delivery. Mater Sci Eng C Mater Biol Appl. 64:29–33.
  • Cao H, Dan Z, He X, Zhang Z, Yu H, Yin Q, et al. 2016. Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano.
  • Carvalho B, Roland LM, Chu LF, Campitelli VA, III, Riley ET. 2007. Single-dose, extended-release epidural morphine (DepoDur™) compared to conventional epidural morphine for post-cesarean pain. Anesth Analg. 105:176–183.
  • Cereda CM, Guilherme VA, Alkschbirs MI, de Brito Junior RB, Tofoli GR, Franz-Montan M, et al. 2016. Liposomal butamben gel formulations: toxicity assays and topical anesthesia in an animal model. J Liposome Res. 1–9.
  • Chatterjee S, Banerjee DK. 2002. Preparation, isolation, and characterization of liposomes containing natural and synthetic lipids. Liposome Methods Protocols. 199:3–16.
  • Cheung Lam AH, Sandoval N, Wadhwa R, Gilkes J, Do TQ, Ernst W, et al. 2016. Assessment of free fatty acids and cholesteryl esters delivered in liposomes as novel class of antibiotic. BMC Res Notes. 9:337.
  • Chou HH, Wang KL, Chen CA, Wei LH, Lai CH, Hsieh CY, et al. 2006. Pegylated liposomal doxorubicin (Lipo-Dox®) for platinum-resistant or refractory epithelial ovarian carcinoma: a Taiwanese gynecologic oncology group study with long-term follow-up. Gynecol Oncol. 101:423–428.
  • Clemons KV, Stevens DA. 2004. Comparative efficacies of four amphotericin B formulations—Fungizone, Amphotec (Amphocil), AmBisome, and Abelcet—against systemic murine aspergillosis. Antimicrob Agents Chemother. 48:1047–1050.
  • Daraee H, Eatemadi A, Abbasi E, Aval SF, Kouhi M, Akbarzadeh A. 2016a. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol 44:410–422.
  • Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. 2016b. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 44:381–391.
  • Davaran S, Rezaei A, Alimohammadi S, Khandaghi AA, Nejati-Koshki K, Nasrabadi HT, Akbarzadeh A. 2014. Synthesis and physicochemical characterization of biodegradable star-shaped poly lactide-co-glycolide–β-cyclodextrin copolymer nanoparticles containing albumin. Adv Nanoparticles. 3:14–22.
  • Davidson EM, Haroutounian S, Kagan L, Naveh M, Aharon A, Ginosar Y. 2016. A novel proliposomal ropivacaine oil: pharmacokinetic-pharmacodynamic studies after subcutaneous administration in pigs. Anesth Analg. 122:1663–1672.
  • de Jong S, Chikh G, Sekirov L, Raney S, Semple S, Klimuk S, et al. 2007. Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN. Cancer Immunol Immunother. 56:1251–1264.
  • Devrim B, Kara A, Vural I, Bozkir A. 2016. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation. Drug Dev Ind Pharm. 1–12.
  • Douer D. 2016. Efficacy and safety of vincristine sulfate liposome injection in the treatment of adult acute lymphocytic leukemia. Oncologist. 21:840–847.
  • Eatemadi A, Daraee H, Zarghami N, Yar H, Akbarzadeh M, Hanifehpour AY. 2016. Nanofiber; synthesis and biomedical applications. Artif Cells Nanomed Biotechnol. 44:111–121.
  • Endo-Takahashi Y, Ooaku K, Ishida K, Suzuki R, Maruyama K, Negishi Y. 2016.Preparation of angiopep-2 peptide-modified bubble liposomes for delivery to the brain. Biol Pharm Bull. 39:977–983.
  • Endreas W, Brüßler J, Vornicescu D, Keusgen M, Bakowsky U, Steinmetzer T. 2016. Thrombin-inhibiting anticoagulant liposomes: development and characterization. ChemMedChem. 11:340–349.
  • Farhood H, Serbina N, Huang L. 1995. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta. 1235:289–295.
  • Fassas A, Anagnostopoulos A. 2005. The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia. Leuk Lymphoma 46:795–802.
  • Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, et al. 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci. 84:7413–7417.
  • Gaidukevich SK, Mikulovich YL, Smirnova TG, Andreevskaya SN, Sorokoumova GM, Chernousova LN, et al. 2016. Antibacterial effects of liposomes ccontaining phospholipid cardiolipin and fluoroquinolone levofloxacin on Mycobacterium tuberculosis with extensive drug resistance. Bull Exp Biol Med. 160:675–678.
  • Gardikis K, Tsimplouli C, Dimas K, Micha-Screttas M, Demetzos C. 2010. New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers. Int J Pharm. 402:231–237.
  • Garello F, Vibhute S, Gunduz S, Logothetis NK, Terreno E, Angelovski G. 2016. Innovative design of Ca-sensitive paramagnetic liposomes results in an unprecedented increase in longitudinal relaxivity. Biomacromolecules. 17:1303–1311.
  • Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L, Swinnen LJ, et al. 1999. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res. 5:3394–3402.
  • Golkar N, Samani SM, Tamaddon AM. 2016. Data on cell growth inhibition induced by anti-VEGF siRNA delivered by Stealth liposomes incorporating G2 PAMAM-cholesterol versus Metafectene(R) as a function of exposure time and siRNA concentration. Data Brief. 8:1018–1023.
  • Gregoriadis G ,Bacon A, Caparrós-Wanderley W, McCormack B. 2002. Plasmid DNA vaccines: entrapment into liposomes by dehydration-rehydration. Methods Enzymol. 367:70–80.
  • Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG, et al. 2001. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res. 7:243–254.
  • Jahadi M, Khosravi-Darani K. 2016. Liposomal encapsulation enzymes: from medical applications to kinetic characteristics. Mini Rev Med Chem.
  • Jayaraman M, Ansell SM, Mui BL, Tam YK, Chen J, Du X, et al. 2012. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew Chem Int. Ed. 51:8529–8533.
  • Kawabata A, Baoum A, Ohta N, Jacquez S, Seo GM, Berkland C, et al. 2012. Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. Cancer Res 72:2057–2067.
  • Kelly C, Jefferies C, Cryan SA. 2011. Targeted liposomal drug delivery to monocytes and macrophages. J Drug Deliv. 2010.
  • Khosravi-Darani K, Pardakhty A, Honarpisheh H, Rao VM, Mozafari MR. 2007. The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy. Micron. 38:804–818.
  • Kurd K, Khandagi AA, Davaran S, Akbarzadeh A. 2016. Cisplatin release from dual-responsive magnetic nanocomposites. Artif Cells Nanomed Biotechnol. 44:1031–1039.
  • Li J, Hu M, Xu H, Yu X, Ye F, Wang K, et al. 2016. Influence of type and proportion of lyoprotectants on lyophilized ginsenoside Rg3 liposomes. J Pharm Pharmacol. 68:1–13.
  • Li Y, Huang L, Tang C, Zhang E, Ding L, Yang L. 2016. Preparation and characterisation of the colistin-entrapped liposome driven by electrostatic interaction for intravenous administration. J Microencapsul. 1–11.
  • Liu S, Li Y, Wang X, Ma J, Zhang L, Xia G. 2016. Preparation, characterization, and antitumor activities of miriplatin-loaded liposomes. J Pharm Sci. 105:78–87.
  • Love KT, Mahon KP, Levins CG, Whitehead KA, Querbes W, Dorkin JR, et al. 2010. Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci. 107:1864–1869.
  • Luo L, Bian Y, Liu Y, Zhang X, Wang M, Xing S, et al. 2016. Gold nanoshells: combined near infrared photothermal therapy and chemotherapy using gold nanoshells coated liposomes to enhance antitumor effect (Small 30/2016). Small. 12:4102.
  • Luo Y, Liu Z, Zhang X, Huang J, Yu X, Li J, et al. 2016. Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo. Int J Nanomed. 11:3111–3129.
  • Mozafari MR. 2010. Nanoliposomes: preparation and analysis. Methods Mol Biol. 605:29–50.
  • Mozafari M, Mortazavi S. 2005. Nanoliposomes: from fundamentals to recent developments. Oxford, UK: Trafford Pub. Ltd.
  • Majidi S, Zeinali Sehrig F, Farkhani SM, Soleymani Goloujeh M, Akbarzadeh A. 2014. Current methods for synthesis of magnetic nanoparticles. Artif Cells Nanomed Biotechnol. 1:1–13.
  • Manconi M, Marongiu F, Castangia I, Manca ML, Caddeo C, Tuberoso CI, et al. 2016. Polymer-associated liposomes for the oral delivery of grape pomace extract. Colloids Surf B Biointerfaces. 146:910–917.
  • Mehrabi M, Esmaeilpour P, Akbarzadeh A, Saffari Z, Farahnak M, Farhangi A, et al. 2016. Efficacy of pegylated liposomal etoposide nanoparticles on breast cancer cell lines. Turk J Med Sci. 46:567–571.
  • Meisel JW, Gokel GW. 2016. A simplified direct lipid mixing lipoplex preparation: comparison of liposomal-, dimethylsulfoxide-, and ethanol-based methods. Sci Rep. 6:27662.
  • Mirakabad FST, Akbarzadeh A, Milani M, Zarghami N, Taheri-Anganeh M, Zeighamian V, Badrzadeh F, Rahmati-Yamchi M. 2016. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells Nanomed Biotechnol. 44:423–430.
  • Mischler R, Metcalfe IC. 2002. Inflexal® V a trivalent virosome subunit influenza vaccine: production. Vaccine. 20:B17–B23.
  • Mishra R, Prabhavalkar KS, Bhatt LK. 2016. Preparation, optimization, and evaluation of Zaltoprofen-loaded microemulsion and microemulsion-based gel for transdermal delivery. J Liposome Res. 1–10.
  • Mohammadian M, Abasi Akbarzadeh EA. 2015. Mesenchymal stem cell-based gene therapy: a promising therapeutic strategy. Artif Cells Nanomed Biotechnol. 1–6. Early Online.
  • Mozafari MR, Flanagan J, Matia‐Merino L, Awati A, Omri A, Suntres ZE, et al. 2006. Recent trends in the lipid‐based nanoencapsulation of antioxidants and their role in foods. J Sci Food Agric. 86:2038–2045.
  • Mozafari MR. 2005. Liposomes: an overview of manufacturing techniques. Cell Mol Biol Lett. 10:711.
  • Mozafari MR. 2006. Nanocarrier technologies: frontiers of nanotherapy. The Netherlands: Springer.
  • Mozafari MR. 2007. Nanomaterials and nanosystems for biomedical applications. The Netherlands: Springer.
  • Nagayasu A, Uchiyama K, Kiwada H. 1999. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv Drug Deliv Rev. 40:75–87.
  • Nasrabadi HT, Abbasi E, Davaran S, Kouhi M, Akbarzadeh A. 2016. Bimetallic nanoparticles: Preparation, properties, and biomedical applications. Artif Cells Nanomed Biotechnol. 44:376–380.
  • Participants VR. 2005. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina. 25:119–134.
  • Patil Y, Amitay Y, Ohana P, Shmeeda H, Gabizon A. 2016. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: intracellular activation and enhanced cytotoxicity. J Control Release. 225:87–95.
  • Pezzoli D, Tallarita E, Rosini E, Candiani G. 2016. Characterization and investigation of redox-sensitive liposomes for gene delivery. Methods Mol Biol. 1445:217–233.
  • Rad MHR, Alizadeh E, Ilkhanizadeh B. 2007. Recurrent laryngeal papillomatosis with bronchopulmonary spread in a 70-year-old man. Tuberk Toraks. 55:299–302.
  • Rahimi-Rad M, Alizadeh E, Samarei R. 2010. Aquatic leech as a rare cause of respiratory distress and hemoptysis, Pneumologia (Bucharest, Romania). 60:85–86.
  • Reshetov V, Zorin V, Siupa A, D’Hallewin MA, Guillemin F, Bezdetnaya L. 2012. Interaction of liposomal formulations of meta‐tetra (hydroxyphenyl) chlorin (Temoporfin) with serum proteins: protein binding and liposome destruction. Photochem Photobiol. 88:1256–1264.
  • Saliba AE, Vonkova I, Deghou S, Ceschia S, Tischer C, Kugler KG, et al. 2016. A protocol for the systematic and quantitative measurement of protein-lipid interactions using the liposome-microarray-based assay. Nat Protoc. 11:1021–1038.
  • Sanchez-Purra M, Ramos V, Petrenko VA, Torchilin VP, Borros S. 2016. Double-targeted polymersomes and liposomes for multiple barrier crossing. Int J Pharm. 511:946–956.
  • Sawant RR, Torchilin VP. 2012. Challenges in development of targeted liposomal therapeutics. AAPS J. 14:303–315.
  • Shabestari Khiabani S, Farshbaf M, Akbarzadeh A, Davaran S. 2016. Magnetic nanoparticles: preparation methods, applications in cancer diagnosis and cancer therapy. Artif Cells Nanomed Biotechnol. 45: 1–12.
  • Siegel D, Tenchov B. 2008. Influence of the lamellar phase unbinding energy on the relative stability of lamellar and inverted cubic phases. Biophys J. 94:3987–3995.
  • Sofou S, Sgouros G. 2008. Antibody-targeted liposomes in cancer therapy and imaging. Expert Opin Drug Deliv. 5:189–204.
  • Sonali RP, Singh G, Sharma L, Kumari B, Koch S, Singh, et al. 2016. RGD-TPGS decorated theranostic liposomes for brain targeted delivery. Colloids Surf B Biointerfaces. 147:129–141.
  • Tanifum EA, Ghaghada K, Vollert C, Head E, Eriksen JL, Annapragada A. 2016. A novel liposomal nanoparticle for the imaging of amyloid plaque by magnetic resonance imaging. J Alzheimers Dis. 52:731–745.
  • Thompson AK, Mozafari MR, Singh H. 2007. The properties of liposomes produced from milk fat globule membrane material using different techniques. Le Lait. 87:349–360.
  • Tong H Wang Y, Lu X, Wang P, Zhao S, Chang H, et al. 2015. On the preparation of transferrin modified artesunate nanoliposomes and their glioma-targeting treatment in-vitro and in-vivo. Int J Clin Exp Med. 8:22045–22052.
  • Usonis V, Bakasenas V, Valentelis R, Katiliene G, Vidzeniene D, Herzog C. 2003. Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal®). Vaccine. 21:4588–4592.
  • Veneti E, Tu RS, Auguste DT. 2016. RGD-targeted liposome binding and uptake on breast cancer cells is dependent on elastin linker secondary structure. Bioconjug Chem. 27:1813–1821.
  • Wang SX, Michiels J, Arien KK, New R, Vanham G, Roitt I. 2016. Inhibition of HIV virus by neutralizing Vhh attached to dual functional liposomes encapsulating dapivirine. Nanoscale Res Lett. 11:350.
  • Wang Y, Wang S, Firempong CK, Zhang H, Wang M, Zhang Y, et al. 2016. Enhanced solubility and bioavailability of naringenin via liposomal nanoformulation: preparation and in vitro and in vivo evaluations. AAPS PharmSciTech.
  • Yu F, Tang X. 2016. Novel long-circulating liposomes consisting of PEG modified beta-sitosterol for gambogic acid delivery. J Nanosci Nanotechnol. 16:3115–3121.
  • YuJi TP, Zhao WM. 2015. [Preparation of baicalein liposome-lyophilized powder and its pharmacokinetics study]. Zhong Yao Cai. 38:2404–2407.
  • Zhang D, Li JY, Wang XC, Yue HX, Hu M, Yu NX, et al. 2015. [Preparation and evaluation of doxorubicin hydrochloride liposomes modified by poly(2-ethyl-2-oxazoline)-cholesteryl methyl carbonate]. Yao Xue Xue Bao. 50:1174–1179.
  • Zhuge Y, Zheng ZF, Xie M, Li Q, Wang LF, Gao F. 2016. Preparation of liposomal amiodarone and investigation of its cardiomyocyte-targeting ability in cardiac radiofrequency ablation rat model. Int J Nanomed. 11:2359–2367.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.